Weisser Nina E, Hall J Christopher
Department of Environmental Biology, University of Guelph, Guelph, ON N1G2W1, Canada.
Biotechnol Adv. 2009 Jul-Aug;27(4):502-20. doi: 10.1016/j.biotechadv.2009.04.004. Epub 2009 Apr 15.
Antibodies (Abs) are some of the most powerful tools in therapy and diagnostics and are currently one of the fastest growing classes of therapeutic molecules. Recombinant antibody (rAb) fragments are becoming popular therapeutic alternatives to full length monoclonal Abs since they are smaller, possess different properties that are advantageous in certain medical applications, can be produced more economically and are easily amendable to genetic manipulation. Single-chain variable fragment (scFv) Abs are one of the most popular rAb format as they have been engineered into larger, multivalent, bi-specific and conjugated forms for many clinical applications. This review will show the tremendous versatility and importance of scFv fragments as they provide the basic antigen binding unit for a multitude of engineered Abs for use as human therapeutics and diagnostics.
抗体(Abs)是治疗和诊断中最强大的工具之一,目前是治疗性分子中增长最快的类别之一。重组抗体(rAb)片段正成为全长单克隆抗体的流行治疗替代品,因为它们更小,具有在某些医学应用中有利的不同特性,可以更经济地生产并且易于进行基因操作。单链可变片段(scFv)抗体是最流行的rAb形式之一,因为它们已被设计成更大、多价、双特异性和缀合形式用于许多临床应用。本综述将展示scFv片段的巨大通用性和重要性,因为它们为多种用作人类治疗和诊断的工程抗体提供了基本的抗原结合单元。